- Home
- HNNA vs INCR Comparison
HNNA vs INCR Comparison
Compare HNNA & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNNA
- INCR
- Stock Information
- Founded
- HNNA 1989
- INCR 1994
- Country
- HNNA United States
- INCR Israel
- Employees
- HNNA N/A
- INCR N/A
- Industry
- HNNA Investment Managers
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- HNNA Finance
- INCR Health Care
- Exchange
- HNNA Nasdaq
- INCR Nasdaq
- Market Cap
- HNNA 82.4M
- INCR 76.7M
- IPO Year
- HNNA N/A
- INCR N/A
- Fundamental
- Price
- HNNA $9.84
- INCR $1.29
- Analyst Decision
- HNNA
- INCR
- Analyst Count
- HNNA 0
- INCR 0
- Target Price
- HNNA N/A
- INCR N/A
- AVG Volume (30 Days)
- HNNA 14.5K
- INCR 11.3K
- Earning Date
- HNNA 05-07-2025
- INCR 04-15-2025
- Dividend Yield
- HNNA 5.52%
- INCR N/A
- EPS Growth
- HNNA 75.66
- INCR N/A
- EPS
- HNNA 1.12
- INCR N/A
- Revenue
- HNNA $33,210,000.00
- INCR $72,420,918.00
- Revenue This Year
- HNNA N/A
- INCR N/A
- Revenue Next Year
- HNNA N/A
- INCR $39.30
- P/E Ratio
- HNNA $9.08
- INCR N/A
- Revenue Growth
- HNNA 38.27
- INCR N/A
- 52 Week Low
- HNNA $6.60
- INCR $1.17
- 52 Week High
- HNNA $13.88
- INCR $3.72
- Technical
- Relative Strength Index (RSI)
- HNNA 31.70
- INCR 25.95
- Support Level
- HNNA $9.61
- INCR $1.36
- Resistance Level
- HNNA $10.73
- INCR $1.49
- Average True Range (ATR)
- HNNA 0.32
- INCR 0.06
- MACD
- HNNA -0.01
- INCR -0.01
- Stochastic Oscillator
- HNNA 12.60
- INCR 3.48
About HNNA Hennessy Advisors Inc.
Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.